FIELD: medicine.
SUBSTANCE: invention describes an immunogenic composition containing as active substances: immunogenic microparticles consisting of antigen-adjuvant microparticle complexes wherein antigen(-s) is (are) enclosed in adjuvant microparticles consisting of amphiphilic polymer(-s) having a poly(hydroxy acid) for hydrophobic segment(-s); and molecules of surfactant containing structure of fatty acid ester, encapsulated in immunogenic microparticle.
EFFECT: immunogenic microparticles provide high immunoactive capacity with respect to a living body, even at small quantity of antigen and/or a small amount of doses and can be used as a vaccine for therapy and/or prevention of infectious diseases, cancer growths.
11 cl, 6 dwg, 6 tbl, 13 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS OF PRODUCING ADJUVANTED VIROSOME AND ADJUVANTED VIROSOMES, OBTAINED BY SAID METHODS | 2014 |
|
RU2694367C2 |
MICROPARTICLE COMPOSITION AND METHODS FOR THEIR PREPARING | 2001 |
|
RU2257198C2 |
COMPOSITIONS OF MENINGOCOCCAL VACCINES WITH ADJUVANTS | 2002 |
|
RU2360699C2 |
METHOD FOR PREPARING VACCINE COMPOSITION CONTAINING AT LEAST ONE ANTIGEN AND AT LEAST ONE ADJUVANT | 2008 |
|
RU2500421C2 |
MICROPARTICLES FOR DELIVERY OF HETEROLOGOUS NUCLEIC ACIDS | 2001 |
|
RU2295954C2 |
MICROPARTICLE AND PHARMACEUTICAL COMPOSITION THEREOF | 2009 |
|
RU2490009C2 |
FUNCTIONALLY RECONSTRUCTED ADJUVANT-CONTAINING VIRUS MEMBRANES | 2004 |
|
RU2348428C2 |
EMULSIONS OF “OIL-IN-WATER” TYPE, WHICH CONTAIN NUCLEIC ACIDS | 2012 |
|
RU2606846C2 |
NANOSTRUCTURED LIPID CARRIERS AND STABLE EMULSIONS AND APPLICATIONS THEREOF | 2018 |
|
RU2816240C2 |
COMPOSITIONS CONTAINING CATION MICROPARTICLES AND DNA HCV E1E2, AND METHODS OF THEIR APPLICATION | 2004 |
|
RU2364419C2 |
Authors
Dates
2016-08-10—Published
2011-08-25—Filed